Jazz Pharmaceuticals plc
JAZZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $8,000 | $6,494 | $7,571 | $7,455 |
| - Cash | $1,326 | $1,190 | $1,862 | $2,413 |
| + Debt | $1,083 | $5,433 | $5,420 | $6,162 |
| Enterprise Value | $7,756 | $10,737 | $11,128 | $11,205 |
| Revenue | $1,126 | $1,046 | $898 | $1,088 |
| % Growth | 7.7% | 16.5% | -17.5% | – |
| Gross Profit | $868 | $929 | $793 | $959 |
| % Margin | 77.1% | 88.9% | 88.3% | 88.2% |
| EBITDA | $236 | -$514 | $139 | $397 |
| % Margin | 20.9% | -49.2% | 15.5% | 36.5% |
| Net Income | $251 | -$718 | -$93 | $191 |
| % Margin | 22.3% | -68.7% | -10.3% | 17.6% |
| EPS Diluted | 4.08 | -11.74 | -1.52 | 3.11 |
| % Growth | 134.8% | -672.4% | -148.9% | – |
| Operating Cash Flow | $475 | $89 | $430 | $399 |
| Capital Expenditures | -$15 | $12 | -$39 | -$13 |
| Free Cash Flow | $459 | $101 | $391 | $385 |